Tag: Statins
Genetic Variants in HMGCR Linked to Increased Cataract Risk
Heterozygous carriers of HMGCR predicted loss-of-function variants had higher risks for developing cataract, cataract surgery
USPSTF Updates Guidance on Statins for Primary Prevention of CVD
Statin use recommended for people aged 40 to 75 years with CV risk factor(s) and higher 10-year risk for a CV event
More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk
More intensive LDL-C-lowering with statin-based therapies linked to reduced risk for recurrent stroke for patients with evidence of atherosclerosis
Meta-Analysis Shows Prevalence of Statin Intolerance Is Low
Prevalence of SI was 9.1 percent overall; significant associations seen for age, female gender, Asian and Black race, obesity, diabetes mellitus
Statin Use May Be Safely Continued During Pregnancy
Higher risk seen for low birth weight and preterm birth with statins, but no tie to congenital anomalies
Statin Use Not Linked to COVID-19 Mortality in Hospitalized Patients
Statin use associated with increased relative risk for severe disease among hospitalized patients with COVID-19
Statins May Be Tied to Lower Risk for COVID-19 Death
Statin treatment tied to moderately lower COVID-19 mortality in large population study accounting for preexisting health conditions and other factors
Fixed-Dose Combination Therapies Reduce Cardiovascular Risk
Fixed-dose combo with BP-lowering meds, statin, and aspirin yields largest reduction in cardiovascular risk
Statin Use Improves Survival in Triple-Negative Breast Cancer
Overall survival, breast cancer-specific survival improved among women with TNBC, but not those without TNBC
Prior Statin Use Linked to Reduced Risk for Death in COVID-19
Risk for death significantly reduced with prior statin and/or antihypertensive use among those with history of CVD and/or hypertension
